Ulrika Westerlind

Dr. Ulrika Westerlind

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CPChristian Pett
Christian Pett
WNWaqas Nasir
Waqas Nasir
CSCarina Sihlbom
Carina Sihlbom
BOBritt‐Marie Olsson
Britt‐Marie Olsson
VCVanessa Caixeta
Vanessa Caixeta
UWUlrika Westerlind
Ulrika Westerlind

11 December 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
JYJin Yu
Jin Yu
MSManuel Schorlemer
Manuel Schorlemer
ATAlejandro Gomez Toledo
Alejandro Gomez Toledo
CPChristian Pett
Christian Pett
CSCarina Sihlbom
Carina Sihlbom
JNJonas Nilsson
Jonas Nilsson

1 March 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
HCHui Cai
Hui Cai
FDFederica Degliangeli
Federica Degliangeli
BPBjörn Palitzsch
Björn Palitzsch
BGBastian Gerlitzki
Bastian Gerlitzki
HKHorst Kunz
Horst Kunz
UWUlrika Westerlind
Ulrika Westerlind

23 January 2017 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
CPChristian Pett
Christian Pett
HCHui Cai
Hui Cai
JLJia Liu
Jia Liu
BPBjörn Palitzsch
Björn Palitzsch
MSManuel Schorlemer
Manuel Schorlemer
UWUlrika Westerlind
Ulrika Westerlind

30 May 2012 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
UWUlrika Westerlind
Ulrika Westerlind
Over the past few years, synthetic methods for the preparation of complex glycopeptides have been drastically improved. The need for homogenous glycopeptides and glycoproteins with defined chemical structures to study diverse biological phenomena further enhances the development of methodologies. Selected recent advances in synthesis and applications, in which glycopeptides or glycoproteins serve as tools for biological studies, are reviewed. The importance of specific antibodies directed to the glycan part, as well as the peptide backbone has been realized during the development of synthetic glycopeptide-based anti-tumor vaccines. The fine-tuning of native chemical ligation (NCL), expressed protein ligation (EPL), and chemoenzymatic glycosylation techniques have all together enabled the synthesis of functional glycoproteins. The synthesis of structurally defined, complex glycopeptides or glyco-clusters presented on natural peptide backbones, or mimics thereof, offer further possibilities to study protein-binding events.

1 February 2014 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
OBOla Blixt
Ola Blixt
UWUlrika Westerlind
Ulrika Westerlind